Immedica Pharma Uk Ltd
11457556
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2025
small
Next accounts due
30/09/2027
Confirmation statement
Last: 09/07/2025
Due 23/07/2026
Industry
Officers
director · Since 04/06/2019
REGIONAL DIRECTOR, PHARMACEUTICALS
BRITISH · UNITED KINGDOM · Age 51
Also on 2 other boards
director · Since 04/06/2019
GENERAL COUNSEL, IMMEDICA PHARMA
SWEDISH · SWEDEN · Age 49
Also on 2 other boards
CompanyRankvs 579+ SIC 46460 peers73
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£273k
Balance sheet strength
Cash
£130k
Cash in the bank
Net Current Assets
£273k
Working capital
Current Assets
£628k
Current Liabilities
£355k
Debtors
£498k
Profit After Tax
£113k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.77 | +£32k |
| 2024 | 1.84 | +£113k |
| 2023 | 1.53 | -£86k |
| 2022 | 2.17 | +£50k |
| 2021 | 1.97 | +£45k |
| 2020 | 1.74 | +£78k |
| 2019 | 1.45 | — |
Derived from filed accounts. Not audited figures.